These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 21355578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y, Lippard SJ.
    Biochemistry; 2003 Mar 11; 42(9):2664-71. PubMed ID: 12614161
    [Abstract] [Full Text] [Related]

  • 3. Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA.
    Wang J, Tochio N, Takeuchi A, Uewaki J, Kobayashi N, Tate S.
    Biochem Biophys Res Commun; 2013 Nov 29; 441(4):701-6. PubMed ID: 24427810
    [Abstract] [Full Text] [Related]

  • 4. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J, Delalande O, Stros M, Elizondo-Riojas MA, Vojtiskova M, Kozelka J, Brabec V.
    Biochemistry; 2003 Feb 11; 42(5):1234-44. PubMed ID: 12564926
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM, Whitehead JP, Raju NL, Lippard SJ.
    Biochemistry; 1997 Dec 02; 36(48):14807-15. PubMed ID: 9398202
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
    Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2001 Jun 26; 40(25):7533-41. PubMed ID: 11412107
    [Abstract] [Full Text] [Related]

  • 10. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
    Stros M.
    Biochemistry; 2001 Apr 17; 40(15):4769-79. PubMed ID: 11294645
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.
    Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.
    Jamieson ER, Lippard SJ.
    Biochemistry; 2000 Jul 25; 39(29):8426-38. PubMed ID: 10913248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling.
    Zhang CX, Chang PV, Lippard SJ.
    J Am Chem Soc; 2004 Jun 02; 126(21):6536-7. PubMed ID: 15161265
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J, Malina J, Novohradsky V, Kasparkova J, Komeda S, Brabec V.
    Biochim Biophys Acta; 2012 Oct 02; 1820(10):1502-11. PubMed ID: 22683702
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.